Our Work
Latham Advises Abridge in US$150 Million Investment Round
February 24, 2024
The California-based team represents the generative AI company in its latest funding round.
Abridge, the leader in generative AI for clinical documentation, has announced an additional US$150 million investment, leveraging momentum from their product’s rapid uptake among health systems throughout the nation. This raise comes just four months after their US$30M Series B, and is one of the largest funding rounds made to date in generative AI for healthcare.
Latham represented Abridge in the investment, with a corporate deal team led by Bay Area partners Brian Patterson and Heather Deixler, and Los Angeles partner Ghaith Mahmood, with associates Ed Grigoryan, Saem Kim, and Nicole Nour.